HER2 status determination is possible either by measuring the copy number of the HER2 gene using in situ hybridization (ISH) or by immunohistochemistry (IHC), which quantifies HER2 receptor on the surface of tumor cells. This evidence concerns the gene ERBB2 and neoplasm.